Medicare Enrolled
Dr. Shumail Haque, D.O.
Pain Medicine (Physical Medicine & Rehabilitation) Physician · Levittown, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Haque from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haque?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Haque
Dr. Shumail Haque is a pain medicine physician in Levittown, NY, with 12 years of NPI registration. Based on federal Medicare data, Dr. Haque performed 5,192 Medicare services across 1,321 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haque received a total of $6,104 from 43 pharmaceutical and/or device companies across 323 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine (physical medicine & rehabilitation) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haque is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 10% volume in NY
$6,104 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,192
Medicare services
Top 10% in NY for pain medicine (physical medicine & rehabilitation) physician
1,321
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~433 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,879 | $109 | $351 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
1,472 | $61 | $150 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
827 | $153 | $500 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
334 | $195 | $1,000 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
261 | $79 | $225 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
44 | $66 | $185 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
40 | $112 | $152 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
37 | $248 | $525 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
37 | $126 | $265 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
34 | $295 | $1,764 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
32 | $125 | $1,269 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
31 | $132 | $500 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $53 | $135 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
27 | $86 | $385 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
25 | $59 | $150 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
23 | $109 | $200 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
16 | $244 | $576 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
16 | $123 | $280 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
14 | $188 | $490 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
12 | $12 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,104
Total received (2018-2024)
Avg $872/year across 7 years
Top 20% in NY for pain medicine (physical medicine & rehabilitation) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
323
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,104 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$971
2023
$1,443
2022
$873
2021
$837
2020
$330
2019
$601
2018
$1,049
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$210
Valinor Pharma, LLC
$171
Bioventus LLC
$114
SCILEX PHARMACEUTICALS INC.
$113
Azurity Pharmaceuticals, Inc.
$80
Collegium Pharmaceutical, Inc.
$61
VERTEX PHARMACEUTICALS INCORPORATED
$49
Medtronic, Inc.
$44
Orexo US, Inc.
$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$22
Virtus Pharmaceuticals LLC
$22
Braeburn Inc.
$20
Indivior Inc.
$16
PFIZER INC.
$13
Top 3 companies account for 51.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$788
Pacira Pharmaceuticals Incorporated
$632
Indivior Inc.
$456
Daiichi Sankyo Inc.
$371
Scilex Pharmaceuticals Inc.
$339
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$326
Collegium Pharmaceutical, Inc.
$275
Abbott Laboratories
$237
Valinor Pharma, LLC
$207
US WorldMeds, LLC
$204
Allergan, Inc.
$183
SCILEX PHARMACEUTICALS INC.
$174
Biohaven Pharmaceuticals, Inc.
$136
Bioventus LLC
$130
PFIZER INC.
$129
RedHill Biopharma Inc.
$122
Pernix Therapeutics Holdings, Inc.
$116
ARBOR PHARMACEUTICALS, INC.
$112
Forte Bio-Pharma LLC
$110
Orexo US, Inc.
$103
Azurity Pharmaceuticals, Inc.
$96
Biohaven Pharmaceutical Holding Company Ltd.
$87
Takeda Pharmaceuticals U.S.A., Inc.
$77
Braeburn Inc.
$66
Arbor Pharmaceuticals, Inc.
$65
Medtronic, Inc.
$58
Virtus Pharmaceuticals LLC
$57
Purdue Pharma L.P.
$54
VERTEX PHARMACEUTICALS INCORPORATED
$49
Assertio Therapeutics, Inc.
$49
FORTE BIO-PHARMA LLC
$42
AbbVie Inc.
$29
BioDelivery Sciences International, Inc.
$29
Allergan Inc.
$26
Eisai Inc.
$26
Kaleo, Inc.
$26
Sentynl Therapeutics, Inc.
$24
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$20
Lilly USA, LLC
$17
AstraZeneca Pharmaceuticals LP
$16
Shionogi Inc
$15
Egalet US Inc
$15
BOSTON SCIENTIFIC CORPORATION
$11
Top 3 companies account for 30.7% of all-time payments
Associated products mentioned in payments ›
ARYMO ER · AXIUM · Amitiza · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BRIXADI · BUNAVAIL 2.1 mg 30-count box · Dayvigo · Dexilant · Durolane · ELYXYB - CELECOXIB · EMGALITY · EVZIO · Entyvio · Evzio · FLECTOR · GELSYN-3 · GENERAL PAIN MANAGEMENT · Gralise · HORIZANT · Horizant · INTELLIS ADAPTIVESTIM · Iovera · KYPHON Balloon Kyphoplasty · LEVORPHANOL TARTRATE · LUCEMYRA · LYRICA · Levorphanol · Levorphanol Tartrate · Lucemyra/Lofexidine · MOVANTIK · Morphabond ER · Movantik · NALOCET · NURTEC ODT · Nucynta · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · RELISTOR · RELISTOR ORAL · SUBLOCADE · SUPARTZ FX SODIUM HYALURONATE · SYMPROIC · SYNCHROMEDII · Symproic · TREXIMET · UBRELVY · XTAMPZA · XTAMPZAER · Xtampza ER · XtampzaER · ZOHYDRO ER · ZTLido · Zipsor · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicine physicians within 10 mi
115
Per 100K population
8.3
County median income
$143,408
Nearest hospital
CHSLI ST JOSEPH HOSPITAL
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Haque is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NY), with low-engagement industry engagement in the top 20% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Haque experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Haque performed 1,879 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haque receive payments from pharmaceutical companies?
Yes. Dr. Haque received a total of $6,104 from 43 companies across 323 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haque's costs compare to other pain medicine physicians in Levittown?
Dr. Haque's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haque) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicine Physicians in Levittown
Browse pain medicine physicians in Levittown ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicine Physicians in NY
Pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicine Physicians in NY
Which NY pain medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Pacira Pharmaceuticals Incorporated Payments to Doctors
See all physicians who received payments from Pacira Pharmaceuticals Incorporated.
By company
Indivior Inc. Payments to Doctors
See all physicians who received payments from Indivior Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology